Mireia Gomez-Angelats, PhD
Mireia joined Topas Therapeutics in October 2022 and is responsible for driving the company’s growth and business development as well as coordinating communications and other strategic corporate activities. She brings over 20 years of international pharmaceutical experience with roles of increasing responsibility in R&D and business development/licensing (BD&L). Prior to joining Topas, Mireia held global senior management positions at leading pharmaceutical companies, including Novartis AG in Switzerland and at Bristol Myers-Squibb in the US. She also held roles in R&D at Janssen (Johnson & Johnson) in the US and at Almirall SA in Barcelona (Spain). In her various positions, she has contributed to the expansion of strategic areas both by driving discovery and development programs and through the execution of a number of strategic deals and partnering activities across immunology, oncology, and cardiometabolic disease areas. Mireia holds a PhD in biochemistry and molecular biology from the University of Barcelona, Spain.